Target intelligence / Profile preview

Immunoglobulin heavy variable 1-69 (IGHV1-69)

Target
IGHV1-69
Molecular classification
Immunoglobulin variable region, Immunoglobulin superfamily, Antigen-binding protein
01

Overview

Immunoglobulin heavy variable 1-69 (IGHV1-69) encodes a variable region of the heavy chain of human immunoglobulins (antibodies), critical for antigen recognition and binding. It is notable for containing hydrophobic residues in its highly variable complementarity-determining region, allowing the generation of antibodies that efficiently bind concealed hydrophobic pockets on antigens, such as the heme-binding site on the IsdB protein of Staphylococcus aureus and the stem region of influenza hemagglutinin. IGHV1-69 is among the most polymorphic and commonly used variable region genes in the human antibody repertoire, frequently appearing in protective immune responses against pathogens, as well as in B cell malignancies and autoimmune conditions. Its variable region participates in the V(D)J recombination that shapes antibody specificity, and antibodies using IGHV1-69 can be monitored with anti-idiotypic antibodies such as G6, which bind a conformational epitope characteristic of IGHV1-69-encoded antibodies. IGHV1-69 is a molecular building block rather than a conventional drug target (like a receptor or enzyme) and is not directly targeted by approved drugs, but its usage as a biomarker is relevant to immuno-oncology and autoimmunity research.

Other names
Immunoglobulin heavy variable 1-69IGHV1-69Ig heavy chain V-I region EUIg heavy chain V-I region SIEIg heavy chain V-I region WOLIGHV1-EIGHV169IGHV1Eimmunoglobulin heavy variable 1-e
02

Mechanism of action

As IGHV1-69 is not directly a therapeutic target, specific mechanisms of action for drugs against this gene are not established. However, anti-idiotypic antibodies such as G6 can selectively bind antibodies encoded by IGHV1-69 and could be considered for immunomodulation.

03

Biological functions

Antigen bindingImmune response (humoral immunity)Formation of antibody diversity (via V(D)J recombination and somatic hypermutation)
04

Disease associations

Cancer (notably B cell malignancies such as chronic lymphocytic leukemia)Infection (preferential usage in antibodies against viral proteins such as influenza hemagglutinin and HIV gp120)Autoimmunity (roles in diseases like systemic lupus erythematosus)
05

Safety considerations

Possibility of autoreactivity (for example, production of pathogenic autoantibodies in autoimmune disease if not properly regulated, especially in the context of clonal expansions)Polymorphisms in IGHV1-69 can affect immune responses or predispose to certain malignancies
06

Biomarkers

IGHV1-69 usage for prognostic stratification in B cell leukemiasG6 idiotope (recognized by anti-idiotypic antibody G6 as a surrogate marker of IGHV1-69 usage and B cell clonal expansions)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-69 (IGHV1-69).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-69 (IGHV1-69).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call